Literature DB >> 10767867

Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10767867

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  250 in total

Review 1.  Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review.

Authors:  Toshi A Furukawa; Hugh McGuire; Corrado Barbui
Journal:  BMJ       Date:  2002-11-02

2.  Racial differences in the availability and use of electroconvulsive therapy for recurrent major depression.

Authors:  Brady G Case; David N Bertollo; Eugene M Laska; Carole E Siegel; Joseph A Wanderling; Mark Olfson
Journal:  J Affect Disord       Date:  2011-12-12       Impact factor: 4.839

3.  A proposed model for economic evaluations of major depressive disorder.

Authors:  Hossein Haji Ali Afzali; Jonathan Karnon; Jodi Gray
Journal:  Eur J Health Econ       Date:  2011-06-02

Review 4.  Mirtazapine versus other antidepressive agents for depression.

Authors:  Norio Watanabe; Ichiro M Omori; Atsuo Nakagawa; Andrea Cipriani; Corrado Barbui; Rachel Churchill; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

5.  Racial and ethnic disparities in postpartum depression care among low-income women.

Authors:  Katy Backes Kozhimannil; Connie Mah Trinacty; Alisa B Busch; Haiden A Huskamp; Alyce S Adams
Journal:  Psychiatr Serv       Date:  2011-06       Impact factor: 3.084

6.  Ten-year trends in quality of care and spending for depression: 1996 through 2005.

Authors:  Catherine A Fullerton; Alisa B Busch; Sharon-Lise T Normand; Thomas G McGuire; Arnold M Epstein
Journal:  Arch Gen Psychiatry       Date:  2011-12

7.  The epidemiology of major depression and ethnicity in the United States.

Authors:  Hector M González; Wassim Tarraf; Keith E Whitfield; William A Vega
Journal:  J Psychiatr Res       Date:  2010-05-27       Impact factor: 4.791

8.  Association Between Process-Based Quality Indicators and Mortality for Patients With Substance Use Disorders.

Authors:  Susan M Paddock; Kimberly A Hepner; Teresa Hudson; Songthip Ounpraseuth; Amy M Schrader; Greer Sullivan; Katherine E Watkins
Journal:  J Stud Alcohol Drugs       Date:  2017-05       Impact factor: 2.582

9.  Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder.

Authors:  Christopher Baethge; Philipp Gruschka; Michael N Smolka; Anne Berghöfer; Tom Bschor; Bruno Müller-Oerlinghausen; Michael Bauer
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

Review 10.  Escitalopram: a pharmacoeconomic review of its use in depression.

Authors:  Katherine F Croom; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.